Valneva SE | Key People and Executives
Frédéric Grimaud
Chairman-Supervisory Board
Maïlys Ferrère
Member-Supervisory Board
Balaji Muralidhar
Member-Supervisory Board
Lisa Shaw-Marotto
Member-Supervisory Board
Sandra E. Poole
Independent Member-Supervisory Board
Ralf Clemens
Independent Member-Supervisory Board
Anne-Marie Graffin
Independent Member-Supervisory Board
Alain Munoz
Member-Supervisory Board
Alexander Ullrich von Gabain
Member-Supervisory Board
James R. Sulat
Vice Chairman-Supervisory Board
Frédéric Grimaud
Chairman-Supervisory Board
Franck Grimaud
Co-President & Chief Business Officer
Thomas Lingelbach
Co-President & Chief Executive Officer
David Lawrence
Chief Financial Officer
Andreas Meinke
Vice President-Pre-Clinical Research & Development
Michael Möhlen
Vice President-Technical Development
Wolfgang Bender
Chief Medical Officer
Klaus Schwamborn
Vice President-Discovery Research & Innovation
Olivier Jankowitsch
Vice President-Global Supply Operations
Frédéric Legros
Vice President-Business Development
Maïlys Ferrère
Member-Supervisory Board
Balaji Muralidhar
Member-Supervisory Board
Louisa Shaw-Marotto
Member-Supervisory Board
Jason Golan
Vice President-Sales & Marketing
Laetitia Bachelot-Fontaine
Head-Investor Relations & Corporate Communications
Gerald Strohmaier
Head-Human Resources
Frédéric Jacotot
Secretary & General Counsel
Sandra E. Poole
Independent Member-Supervisory Board
Ralf Clemens
Independent Member-Supervisory Board
Anne-Marie Graffin
Independent Member-Supervisory Board
Alain Munoz
Member-Supervisory Board
Alexander Ullrich von Gabain
Member-Supervisory Board
James R. Sulat
Vice Chairman-Supervisory Board
| Address |
Campus Bio-Ouest 6
Saint-Herblain Lorraine 44800
France
|
|
Employees
|
- |
| Website |
http://www.valneva.com |
| Updated |
07/08/2019 |
| Valneva SE is a biotech company which engages in the development, production, and marketing of vaccine and preventive medicine. It operates through the following segments: Commercialized Vaccines, Technologies and Services, and Vaccine Candidates. The Commercialized Vaccines segment includes currently marketed vaccines of the group such as JEV and DUKORAL. |
